{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:25:23Z","timestamp":1790144723755,"version":"4.0.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To compare within-subject efficacy and safety of intravitreal dexamethasone implant and topical carbonic anhydrase inhibitors in the treatment of retinitis pigmentosa\u2013related cystoid macular edema.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients with bilateral retinitis pigmentosa\u2013related cystoid macular edema were treated with intravitreal dexamethasone implant in one eye and topical carbonic anhydrase inhibitors in the contralateral eye. The primary endpoint was a change in central macular thickness. Secondary endpoints were changes in best-corrected visual acuity and microperimetric central retinal sensitivity. Intraocular pressure and other ocular complications were evaluated for safety assessment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Nine patients were recruited for this 12-month follow-up study. Central macular thickness was significantly lower in intravitreal dexamethasone implant\u2013treated eyes than in topical carbonic anhydrase inhibitors\u2013treated eyes at Months 1 and 7, whereas mean best-corrected visual acuity was better in eyes treated with topical carbonic anhydrase inhibitors at Month 12 (borderline significant <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0510). There was no difference in microperimetric sensitivity between the two treatments. Three patients developed ocular hypertension after intravitreal dexamethasone implant. Intravitreal dexamethasone implant showed an effect on the contralateral eye in five of nine patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Intravitreal dexamethasone implant was more effective than topical carbonic anhydrase inhibitors in reducing retinitis pigmentosa\u2013related cystoid macular edema 1 month after treatment. Corticosteroids can play a key role in the management of retinitis pigmentosa\u2013related cystoid macular edema; however, their routes, timing, and modes of administration should be further explored.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004039","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T21:00:57Z","timestamp":1704229257000},"page":"852-860","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["DEXAMETHASONE IMPLANT VERSUS TOPICAL CARBONIC ANHYDRASE INHIBITORS IN PATIENTS WITH BILATERAL RETINITIS PIGMENTOSA\u2013RELATED CYSTOID MACULAR EDEMA"],"prefix":"10.1097","volume":"44","author":[{"given":"Leonardo","family":"Colombo","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Montesano","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital, NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Di Domenico","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Colizzi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rissotto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Maltese","sequence":"additional","affiliation":[{"name":"MAGI's Lab S.r.l., Rovereto, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bertelli","sequence":"additional","affiliation":[{"name":"MAGI's Lab S.r.l., Rovereto, Italy; and"},{"name":"MAGI Euregio s.c.s., Bolzano, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Autelitano","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rossetti","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,18]]},"reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/bjo.2008.138560","article-title":"The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography","volume":"92","author":"Hajali","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/IAE.0b013e31809862aa","article-title":"Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial","volume":"28","author":"Adackapara","year":"2008","journal-title":"Retina"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bjophthalmol-2016-309376","article-title":"Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention","volume":"101","author":"Strong","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.survophthal.2017.09.009","article-title":"Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review","volume":"63","author":"Bakthavatchalam","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00919100","article-title":"Long-term treatment of retinitis pigmentosa with acetazolamide. A pilot study","volume":"231","author":"Orzalesi","year":"1993","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00417-012-2249-4","article-title":"Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa","volume":"251","author":"Srour","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00417-017-3660-7","article-title":"Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: a pilot study","volume":"255","author":"Sudhalkar","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/IAE.0000000000001542","article-title":"Intravitreal dexamethasone implant in retinitis pigmentosa\u2013related cystoid macular edema","volume":"38","author":"Mansour","year":"2018","journal-title":"Retina"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1089\/jop.2018.0153","article-title":"Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa","volume":"36","author":"Veritti","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/IAE.0000000000002589","article-title":"A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa","volume":"40","author":"Park","year":"2020","journal-title":"Retina"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/DDDT.S138922","article-title":"Widening use of dexamethasone implant for the treatment of macular edema","volume":"11","author":"Bonfiglio","year":"2017","journal-title":"Drug Des Dev Ther"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archophthalmol.2010.172","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00417-011-1904-5","article-title":"The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa","volume":"250","author":"Ikeda","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1167\/iovs.14-15995","article-title":"Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa","volume":"56","author":"Liew","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.2006.107466","article-title":"Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa","volume":"91","author":"Fishman","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2005.12.030","article-title":"Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa","volume":"141","author":"Grover","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bjophthalmol-2012-303005","article-title":"Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa","volume":"97","author":"Ikeda","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/IAE.0000000000003286","article-title":"Recurrence rate of cystoid macular edema with topical dorzolamide treatment and its risk factors in retinitis pigmentosa","volume":"42","author":"Shimokawa","year":"2022","journal-title":"Retina"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/eye.2008.266","article-title":"Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa","volume":"23","author":"Oishi","year":"2009","journal-title":"Eye"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1167\/iovs.12-10149","article-title":"Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa","volume":"54","author":"Kim","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s41598-023-27994-6","article-title":"Characterizing macular edema in retinitis pigmentosa through a combined structural and microvascular optical coherence tomography investigation","volume":"13","author":"Arrigo","year":"2023","journal-title":"Sci Rep"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"e0145663","DOI":"10.1371\/journal.pone.0145663","article-title":"Morphology and function over a one-year follow up period after intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema","volume":"10","author":"Mastropasqua","year":"2015","journal-title":"PLoS ONE"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/3095961","article-title":"Evaluation of the effectiveness of treatment with dexamethasone intravitreal implant in cystoid macular edema secondary to retinal vein occlusion","volume":"2018","author":"Donati","year":"2018","journal-title":"Biomed Res Int"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s00417-013-2447-8","article-title":"Unilateral intravitreal dexamethazone implant for bilateral retinitis pigmentosa-related macular edema","volume":"251","author":"Alhassan","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5935\/0004-2749.20200013","article-title":"Unilateral intravitreal dexamethasone implant for diabetic macular edema: effect in the contralateral eye","volume":"83","author":"Pareja-R\u00edos","year":"2020","journal-title":"Arq Bras Oftalmol"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/ICB.0000000000000122","article-title":"Bilateral effect of unilateral dexamethasone intravitreal implant in a case of noninfectious uveitic macular edema and vitritis","volume":"9","author":"Habot-Wilner","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/ojo.OJO_68_2016","article-title":"Effect of intravitreal dexamethasone implant on the contralateral eye in recalcitrant radiation maculopathy","volume":"12","author":"Gulati","year":"2019","journal-title":"Oman J Ophthalmol"},{"key":"R30-20250605","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/ICB.0b013e31825a300f","article-title":"Topical steroidal and nonsteroidal antiinflammatory drugs for the treatment of cystoid macular edema in retinitis pigmentosa","volume":"7","author":"Park","year":"2013","journal-title":"Retin Cases Brief Rep"},{"key":"R31-20250605","doi-asserted-by":"crossref","first-page":"e000107","DOI":"10.1136\/bmjophth-2017-000107","article-title":"Efficacy of additional topical betamethasone in persistent cystoid macular oedema after carbonic anhydrase inhibitor treatments in retinitis pigmentosa","volume":"3","author":"Kitahata","year":"2018","journal-title":"BMJ Open Ophthalmol"},{"key":"R32-20250605","doi-asserted-by":"crossref","first-page":"10177","DOI":"10.1096\/fj.201900414R","article-title":"Rescuing cones and daylight vision in retinitis pigmentosa mice","volume":"33","author":"Guadagni","year":"2019","journal-title":"FASEB J"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:02:12Z","timestamp":1749142932000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004039"}},"subtitle":["A Prospective, Paired-Eye Pilot Study"],"short-title":[],"issued":{"date-parts":[[2024,4,18]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004039","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,18]]}}}